Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt

被引:35
|
作者
Mamiya, Y [1 ]
Kanazawa, H [1 ]
Kimura, Y [1 ]
Narahara, Y [1 ]
Yamate, Y [1 ]
Nakatsuka, K [1 ]
Sakamoto, C [1 ]
机构
[1] Nippon Med Coll, Dept Internal Med 3, Bunkyo Ku, Tokyo 1138603, Japan
关键词
transjugular intrahepatic portosystemic shunt; complications; hepatic encephalopathy; liver cirrhosis; portal hypertension;
D O I
10.1016/j.hepres.2004.09.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The aim of this prospective study was to investigate the incidence, clinical features and the short- and long-term clinical course of hepatic encephalopathy (HE) after transjugular intrahepatic portosysternic shunt (TIPS) in Japanese patients. Eighty-seven consecutive patients with liver cirrhosis presenting with complications of portal hypertension underwent TIPS. The mean follow-up period after TIPS was 866 days. During the follow-up, HE occurred in 52% of patients throughout the follow-up period. The cumulative incidence of postTIPS HE was 50.5 +/- 5.6% at 1 year (mean +/- S.D.). Most cases (89%) occurring within 7 days were easily controlled by the conventional therapy. Only two patients developed severe chronic HE, which was treated by reducing the shunt diameter. Older age, indication for TIPS (ascites) and higher retention rate of indocyanine green at 15 min were identified as risk factors for post-TIPS HE. During long-term follow-up, the incident of post-TIPS HE decreased among survivals. The cumulative survival rate was similar in patients with or without post-TIPS HE. Our results indicate that post-TIPS HE are a frequent complication, particularly in the early months after TIPS. However., it can be easily managed in the majority of patients. The development of post-TIPS HE is not associated with poor prognosis in TIPS patients. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:162 / 168
页数:7
相关论文
共 50 条
  • [11] Pathological Predictors of Shunt Stenosis and Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt
    He, Fuliang
    Dai, Shan
    Xiao, Zhibo
    Wang, Lei
    Yue, Zhendong
    Zhao, Hongwei
    Zhao, Mengfei
    Lin, Qiushi
    Dong, Xiaoqun
    Liu, Fuquan
    BIOMED RESEARCH INTERNATIONAL, 2016, 2016
  • [12] No effect of albumin infusion on the prevention of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt
    Riggio, Oliviero
    Nardelli, Silvia
    Pasquale, Chiara
    Pentassuglio, Ilaria
    Gioia, Stefania
    Onori, Eugenia
    Frieri, Camilla
    Salvatori, Filippo Maria
    Merli, Manuela
    METABOLIC BRAIN DISEASE, 2016, 31 (06) : 1275 - 1281
  • [13] Application of fecal microbial transplantation in hepatic encephalopathy after transjugular intrahepatic portosystemic shunt
    Li, Jun
    Wang, Dan
    Sun, Jingping
    MEDICINE, 2022, 101 (03)
  • [14] No effect of albumin infusion on the prevention of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt
    Oliviero Riggio
    Silvia Nardelli
    Chiara Pasquale
    Ilaria Pentassuglio
    Stefania Gioia
    Eugenia Onori
    Camilla Frieri
    Filippo Maria Salvatori
    Manuela Merli
    Metabolic Brain Disease, 2016, 31 : 1275 - 1281
  • [15] Risk factors for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation in patients with liver cirrhosis
    Tong, Huan
    Gan, Can
    Wei, Bo
    Wang, Zhi Dong
    Li, Xiao Dan
    Qian, Shuai Jie
    Huan, Hui
    Zhang, Lin Hao
    Yang, Zhu
    Chen, Yi Long
    Gu, Yong Hong
    Chen, Liu Xiang
    Yang, Yu Hang
    Wu, Hao
    Tang, Cheng Wei
    JOURNAL OF DIGESTIVE DISEASES, 2021, 22 (01) : 31 - 40
  • [16] Analysis of independent risk factors for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis combined with diabetes
    Chen, Huan
    Cai, Zihao
    Da, Binlin
    Wang, Chunxiang
    Yin, Qin
    Xiao, Jiangqiang
    Zhang, Ming
    Zhuge, Yuzheng
    Zhang, Feng
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2025, 37 (02) : 214 - 218
  • [17] Hepatic encephalopathy treatment after transjugular intrahepatic portosystemic shunt: a new perspective on the gut microbiota
    Xu, Xiaotong
    Zhu, Tong
    Jing, Changyou
    Jiang, Minjie
    Fu, Yunlai
    Xie, Fang
    Meng, Qinghua
    Li, Jianjun
    FRONTIERS IN MEDICINE, 2025, 12
  • [18] Reversal of hemolytic anemia and hepatic encephalopathy by transjugular intrahepatic portosystemic shunt occlusion
    Sindhu A. Abraham
    Current Treatment Options in Gastroenterology, 2000, 3 (2) : 105 - 109
  • [19] Spleen volume is associated with overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with portal hypertension
    Zhao, Chun-Juan
    Ren, Chao
    Yuan, Zhen
    Bai, Guo-Hui
    Li, Jin-Yu
    Gao, Long
    Li, Jin-Hui
    Duan, Ze-Qi
    Feng, Dui-Ping
    Zhang, Hui
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2024, 16 (07):
  • [20] Overweight/Obesity Increases the Risk of Overt Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Cirrhotic Patients
    Gu, Lihong
    Yin, Xiaochun
    Cheng, Yang
    Wang, Xixuan
    Zhang, Ming
    Zou, Xiaoping
    Wang, Lei
    Zhuge, Yuzheng
    Zhang, Feng
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (04):